1. Home
  2. FCEL vs BBOT Comparison

FCEL vs BBOT Comparison

Compare FCEL & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FuelCell Energy Inc.

FCEL

FuelCell Energy Inc.

HOLD

Current Price

$25.00

Market Cap

725.8M

Sector

Energy

ML Signal

HOLD

Logo BridgeBio Oncology Therapeutics Inc.

BBOT

BridgeBio Oncology Therapeutics Inc.

HOLD

Current Price

$8.58

Market Cap

705.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCEL
BBOT
Founded
1969
2016
Country
United States
United States
Employees
629
106
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
725.8M
705.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FCEL
BBOT
Price
$25.00
$8.58
Analyst Decision
Hold
Strong Buy
Analyst Count
4
7
Target Price
$8.31
$24.00
AVG Volume (30 Days)
10.7M
362.8K
Earning Date
06-05-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.77
N/A
Revenue Next Year
$42.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.78
$7.60
52 Week High
$26.90
$14.87

Technical Indicators

Market Signals
Indicator
FCEL
BBOT
Relative Strength Index (RSI) 71.51 49.24
Support Level $6.55 $8.08
Resistance Level N/A $9.73
Average True Range (ATR) 3.16 0.57
MACD 0.76 0.11
Stochastic Oscillator 85.07 59.04

Price Performance

Historical Comparison
FCEL
BBOT

About FCEL FuelCell Energy Inc.

FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.

About BBOT BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.

Share on Social Networks: